Atlas Trials

The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer

Clinical trial NCT04936334 · COMPLETED

Trial details

NCT number
NCT04936334
Sponsor
Clinton Bahler
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2021-06-11
Primary completion
2022-07-18
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.